Elevated Baseline CA19-9 Levels Correlate With Adverse Prognosis in Patients With Early- Or Advanced-Stage Pancreas Cancer

Medical Oncology - United States
doi 10.1007/s12032-012-0278-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search